Introduction: We sought to identify the role of provider and facility characteristics in receipt of radical prostatectomy (RP) or external beam radiation therapy (EBRT) and adherence to quality of care measures in men with localized prostate cancer (PCa).
R adical prostatectomy (RP) and external beam radiation therapy (EBRT) are the dominant forms of definitive treatment for localized prostate cancer (PCa). [1] [2] [3] [4] Given limitations of randomized controlled trials showing a clear oncological benefit to a particular treatment, there is significant variation in definitive treatment selection which is influenced by sociodemographic, clinical, and tumor-risk characteristics as well as geographic location. 3, [5] [6] [7] This variation in the use of RP or EBRT also reflects preference-sensitive decision making, wherein patient and the provider's preferences strongly influence treatment choice. 5, [8] [9] [10] Other factors influencing treatment choice are unknown. One study found that unexplained patient and clinician factors accounted for 70% of the unmeasured variation. 2, 4, 11, 12 Characteristics of the provider such as date of graduation and academic affiliation of the treatment facility have been shown to influence practice patterns. 2, 13 There is a need to better understand the contribution of these and other provider/facility-level factors such as the practice characteristics (group vs. solo) and ownership of facility (government vs. for profit) on treatment selection. 2, 3, 6, 14 In addition to treatment choice, provider-level variables may also affect quality of care received. There has been a nation-wide effort over the past 2 decades to establish and assess quality of PCa care benchmarks. [6] [7] [8] 10, 15 Application of the Donabedian model 3, 7, 9, 16 to consider structures, processes, and outcomes in PCa care has yielded Research and Development Corporation (RAND), National Quality Forum (NQF) endorsed quality indicators, such as avoiding bone scans in staging low-risk PCa. 2, 8, 9, 11 There is significant variation in the adherence to such measures 4, 12, 17 and it is unclear whether and to what extent provider/facility-level factors may impact quality of PCa care.
The primary objective of this study was to assess the association of provider and facility-level characteristics (in addition to demographic and clinical determinants) on use of RP versus EBRT for patients with localized PCa. The secondary objective was to assess the influence of provider/facility characteristics on adherence to quality of care metrics for the treatment of PCa. Sampling methodology for random selection of cases by race/ ethnicity, registry, and facility characteristics has been previously described. 5 Treatment-related variables for these cases were verified and supplemented by reabstracting hospital records in addition to obtaining treatment information from physicians' offices, ambulatory surgical centers, radiation treatment facilities, and long-term care facilities for some cases.
MATERIALS AND METHODS

The
We restricted our analysis to patients with localized PCa who received definitive initial treatment (RP or EBRT) within 6 months of pathology-confirmed diagnosis, accounting for 57% of the CDC-POC-BP cohort (those receiving RP followed by adjuvant or salvage EBRT [n = 108] were excluded). EBRT included either 3D conformal radiation therapy (CRT) or intensity-modulated radiation therapy (IMRT) and external radiation with unspecified modality. RP included both open and minimally invasive surgical approaches (but the specific type of surgery received was not specified in the data abstracted). We focused only on men receiving either of these 2 most common forms of definitive therapy and excluded those treated with brachytherapy, either alone or in combination with EBRT (due to the different clinical indications for treatment between brachytherapy and RP or EBRT alone in this time period). We also excluded those initially receiving conservative therapy (active surveillance, expectant management, or primary androgen deprivation therapy [ADT] ). Finally, we excluded 33 patients who died within 6 months after diagnosis with no record of treatment, 239 patients who underwent cryoradical or nonradical prostate surgery and 273 patients with missing information on, American Joint Committee on Cancer Clinical (AJCC) stage, prostate-specific antigen (PSA), and/or Gleason Score. After these exclusions our analytic sample consisted of 4491 patients (2861 who were treated with RP and 1630 who were treated with EBRT).
Patient Covariates
Categories used for each covariate are shown in Table 1 . Demographic covariates included age at diagnosis, race/ ethnicity, marital status, and insurance status. In addition, the 2000 US Census tract-specific data based on the patient's residence location at diagnosis was used to categorize level of urbanization and socioeconomic status (SES) (based on poverty level and educational ascertainment). 14, 18, 19 The registry location of the patient was categorized as A to G. Patient comorbidity severity was determined using the Adult Comorbidity Evaluation 27 (ACE-27), a validated chart-based comorbidity instrument. [1] [2] [3] [4] Recurrence risk groups were defined according to the National Comprehensive Cancer Network (NCCN) guidelines for PCa (version 1.2002) , which utilizes a combination of clinical T stage (AJCC, American Joint Committee on Cancer Clinical Staging System, 6th ed.), Gleason Score from transrectal ultrasound guided biopsy and PSA level. The definitions of the risk groups 
Provider and Facility Characteristics
Provider (the physician whom diagnosed the malignancy) and facility characteristics were linked to patients using external information sources that were available for 2004. Provider year of graduation from medical school (categorized by decade starting from 1950 to 1990) and type of practice (solo vs. group) was obtained for the treatment year from the Medicare Physician Identification and Eligibility Registry (MPIER) File, maintained by the US Centers for Medicare and Medicaid Services as previously described. 3, [5] [6] [7] Facility ownership (for profit vs. nonprofit/government funded) and facility teaching status (based on the presence of postgraduate medical training) corresponding to the treatment year were determined from the American Hospital Directory, which includes data from the Graduate Medical Education Database (American Medical Association, Chicago, IL). The distance (miles) from the primary treatment (surgery or radiation) facility for each patient was determined by the great circle distance and was categorized by quartiles (< 5, 5 to 9, 10 to 14, and 15+ miles). County-level population estimates of males in 2004 from surveillance, epidemiology, and end results program and number of urologists obtained from the Area Resource File were used to calculate urologist density per 100,000 men as previously described. 5, [8] [9] [10] On the basis of quintiles of the residential distribution of patients, ratio-cut points were 0, > 0 to 5.6, > 5.6 to 6.8, > 6.8 to 10.6, and > 10.6 to 26.0 urologists/100,000 men.
Quality of Care Measures
We utilized 2 quality of care indicators from the RAND consensus method and the Physician Consortium for Performance Improvement (PCPI) that are endorsed by the American Urological Association (AUA) and could be assessed from variables available from the CDC-POC-BP cohort. 2, 4, 11, 12 These included (1) receiving a staging bone scan that is not recommended for patients with NCCN low-risk PCa and (2) receipt of concomitant ADT in those undergoing EBRT for NCCN high-risk PCa. 2, 13 In addition, we also considered surgical quality of care in those treated by RP, including (1) receipt of pelvic lymph node dissection (PLND) in patients with NCCN intermediate or high-risk PCa at the time of RP 2,3,6,14 and (2) achieving negative surgical margins in patients with pathologic T2 disease.
Statistical Analyses
The data were analyzed using SAS software (Proc Genmod). Weights were calculated by the inverse of the sampling fractions used by each registry for each sampling stratum to represent the source population. Unadjusted associations between initial treatment (RP or EBRT) and sociodemographic, location, patient comorbidity, NCCN risk group, provider characteristics, and patient distance to provider variables were assessed by the χ 2 tests. We utilized multivariable generalized estimating equation (GEE) models with a logit link to account for correlation in outcomes based on treatment facility. This analysis was performed on a subset of patients (n = 3875) in whom facility-level information was available. Physician identifiers were not available in our cohort to adjust for correlation at this level. We included variables that showed associations in unadjusted analyses (P < 0.1) and/or those deemed a priori to be clinically important. The final model to determine predictors of RP (vs. EBRT) included age, race/ethnicity, SES, insurance, registry, ACE-27 comorbidity severity, NCCN risk group, provider's medical school graduation date, practice type (solo vs. group), facility ownership, teaching status of facility, distance to treatment facility, and regional urologist density. One registry (labeled as "E") did not contribute data on provider characteristics and was excluded from the final model.
In addition, 4 separate GEE models with each of the quality of care measures as the outcome variable were constructed to determine the association between patient and provider/facility characteristics with these outcome measures. Variable selection for each of these models was based on the same technique for assessing predictors of definitive treatment modality. Race/ ethnicity was retained in all models as there is potential evidence that race impacts multiple measures of quality of surgical care, and specifically the utilization of PLND. [6] [7] [8] 10, 15 As we were specifically interested in the association of provider and facilitylevel variables on quality of care measures, all these variables were included in all models.
RESULTS
Treatment Received
A total of 2861 (66.2% based on weighed percentages) men underwent RP, whereas 1630 (33.8%) were treated by EBRT. The breakdown of EBRT by treatment modality included IMRT, 3D-CRT, and unspecified external beam treatment in 548 (33.6%), 102 (6.3%), and 980 (60.1%) patients, respectively. The characteristics of patients receiving RP or EBRT as initial treatment are summarized in Table 1 . In comparison with those receiving EBRT, younger patients were more likely to receive RP than older patients (eg, 88.9% of those below 60 had a RP compared with 11.3% of those above 75). Black patients and those with lower SES were less likely to receive RP compared with those in other racial/ethnic groups or in higher SES groups. There was evidence of significant variation in the utilization of RP between registries, ranging from 56.3% to 76.0%. Patients with no medical comorbidities were more likely to receiving RP compared with those with comorbidities of any severity (eg, 76.0% of those with no comorbidities had a RP compared with 53.5% of those with severe comorbidities). Likewise, men with in the low NCCN risk group were more likely to receive RP compared with those in the high-risk group (71.8% vs. 47.5%). There were statistically significant differences in provider and facility characteristics for patients receiving RP versus EBRT (Table 2) . Specifically, those who received care from a for-profit facility (vs. nonprofit) as well as those seen at a hospital that had a teaching designation (vs. nonteaching) were more likely to receive a RP.
GEE regression analysis (used to account for the effect of multiple patients linked to a facility) was utilized to assess the association of patient and provider/facility characteristics with the receipt of RP versus EBRT (Table 3 , n = 2953 used in model, after exclusion of cases with missing values). Demographic factors were related to treatment choice. Older age (adjusted odds ratio [OR], 0.07; 95% confidence interval [CI], 0.05-0.11 for 70 to 74 vs. below 60), as well as black race versus white (OR, 0.47; 95% CI, 0.30-0.73), and being single versus married (OR, 0.72; 95% CI, 0.54-0.98) were associated with a decreased risk of receiving RP. Clinical factors including greater severity of comorbidities (vs. none) and high NCCN risk group (vs. low) were also associated with lower risk of having a RP. High versus low SES was associated with an increased risk of receiving RP as was residing in an urban setting versus rural. Among the provider/facility variables, group versus solo practice (OR, 0.47; 95% CI, 0.25-0.91) was associated with a decreased risk of RP. Although not statistically significant after accounting for clustering by facility, there was a decreased risk for receiving a RP at a teaching facility (vs. nonteaching), and an increased risk of RP if seen at a forprofit facility (vs. nonprofit/government facility).
Quality of Care Measures
A total of 1455 (of 1575) NCCN low-risk PCa patients had information available on receipt of bone scan. There were 444 patients (30.5%) who received a bone scan that was not recommended and the GEE regression model that identified predictors of this are shown in Table 4 . Compared with whites, blacks (OR, 1.80; 95% CI, 1.00-3.25) and Asian Pacific Islander (API)/American Indian (AI)/Alaska Native (AN)'s (OR, 2.76; 95% CI, 1.16-6.56) had an increased risk of receiving a bone scan that was not recommended. Medicaidinsured patients (OR, 2.78; 95% CI, 1.24-6.26) also had an increased risk of a bone scan that was not recommended. While none of the facility variables were significantly associated with the use of bone scans, there was an increased risk of receiving a bone scan that was not recommended in areas with a higher density of urologists. Surgical quality of care was also assessed by determining predictors of achieving a negative surgical margin in patients with organ confined (pathologic T2) PCa (Supplementary  Table 2 , Supplemental Digital Content 2, http://links.lww.com/ AJCO/A194, n = 620 used in model). High versus low preoperative NCCN risk was associated with a decreased risk of achieving a negative margin (OR, 0.32; 95% CI, 0.13-0.75). Further, higher urologist density was associated with increased risk of achieving a negative margin (OR, 3.30; 95% CI, 1.58-6.90 for 10.6 to 26 urologist/100,000 men vs. none).
Quality of care for radiation therapy (EBRT) was assessed by the concomitant prescription of ADT during treatment of NCCN-defined high-risk PCa. The regression model was limited to 224 patients (after including those for whom outpatient records had been reviewed) and but did not converge.
DISCUSSION
We found that that provider and facility characteristics influenced both the selection of initial treatment as well as measures of quality of care for the treatment of localized PCa after taking into account sociodemographic and clinical factors. Treatment choice for localized PCa is highly related to preferences of both patients and physicians. In addition, geographic location (including factors related to reimbursement and medicolegal climate), hospital factors (volume, expertise), access to care (both distance as well as information), tumor-related risk, and patient factors (including comorbidities, baseline urinary, and erectile function) will remain relevant in treatment selection. 3, 7, 9, 16 Although it is clear that these factors are potentially important in treatment selection, we sought to additionally assess whether they may impact quality of care as well, which is also multifactorial. 2, 8, 9, 11 Specifically, we found that the nature of the practice organization (group vs. solo) was related to the treatment selection, whereas higher regional urologist density was related to increased risk of receiving an inappropriate bone scan. Urological density, on the other hand, was related to higher likelihood of achieving a negative surgical margin. Unexpectedly more recent year of graduation and being 
